Cargando…

Histone methyltransferase SMYD2: ubiquitous regulator of disease

SET (Suppressor of variegation, Enhancer of Zeste, Trithorax) and MYND (Myeloid-Nervy-DEAF1) domain-containing protein 2 (SMYD2) is a protein methyltransferase that methylates histone H3 at lysine 4 (H3K4) or lysine 36 (H3K36) and diverse nonhistone proteins. SMYD2 activity is required for normal or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Xin, Jiang, Xue-Jun, Fang, Ze-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670139/ https://www.ncbi.nlm.nih.gov/pubmed/31370883 http://dx.doi.org/10.1186/s13148-019-0711-4

Ejemplares similares

Histone methyltransferase Smyd3 is a new regulator for vascular senescence
por: Yang, Di, et al.
Publicado: (2020)

Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation
por: Su, Haibi, et al.
Publicado: (2022)

Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3
por: Foreman, Kenneth W., et al.
Publicado: (2011)

Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
por: Kim, Kwangho, et al.
Publicado: (2023)

Histone methyltransferase Smyd2 contributes to blood‐brain barrier breakdown in stroke
por: Wang, Jinghuan, et al.
Publicado: (2022)

Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity
por: Su, Zhenghua, et al.
Publicado: (2022)

Perm1 regulates cardiac energetics as a downstream target of the histone methyltransferase Smyd1
por: Oka, Shin-ichi, et al.
Publicado: (2020)

Analysis of the Substrate Specificity of the SMYD2 Protein Lysine Methyltransferase and Discovery of Novel Non‐Histone Substrates
por: Weirich, Sara, et al.
Publicado: (2019)

Smyd3, a histone methyltransferase, modulates the growth and differentiation of human cardiac stem cells
por: Gurusamy, Narasimman, et al.
Publicado: (2014)

Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases
por: Padilla, Alyssa, et al.
Publicado: (2023)

Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model
por: Williams, Jamal B., et al.
Publicado: (2023)

The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells
por: Kojima, Machiko, et al.
Publicado: (2020)

Crystal Structures of Histone and p53 Methyltransferase SmyD2 Reveal a Conformational Flexibility of the Autoinhibitory C-Terminal Domain
por: Jiang, Yuanyuan, et al.
Publicado: (2011)

Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation
por: Zhu, Li, et al.
Publicado: (2023)

SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stress
por: Zipin-Roitman, Adi, et al.
Publicado: (2017)

Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization
por: Yoshioka, Yuichiro, et al.
Publicado: (2017)

Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer
por: Reynoird, Nicolas, et al.
Publicado: (2016)

Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
por: Li, Linda Xiaoyan, et al.
Publicado: (2018)

Role of Muscle-Specific Histone Methyltransferase (Smyd1) in Exercise-Induced Cardioprotection against Pathological Remodeling after Myocardial Infarction
por: Liang, Qiaoqin, et al.
Publicado: (2020)

The SMYD3 methyltransferase promotes myogenesis by activating the myogenin regulatory network
por: Codato, Roberta, et al.
Publicado: (2019)

Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase
por: Talibov, Vladimir O., et al.
Publicado: (2021)

Lysine methyltransferase SMYD2 inhibits antiviral innate immunity by promoting IRF3 dephosphorylation
por: Wu, Jiacheng, et al.
Publicado: (2023)

The Methyltransferase Smyd1 Mediates LPS-Triggered Up-Regulation of IL-6 in Endothelial Cells
por: Shamloul, Ahmed, et al.
Publicado: (2021)

The lysine methyltransferase SMYD2 is required for normal lymphocyte development and survival of hematopoietic leukemias.
por: Brown, Mark A., et al.
Publicado: (2020)

The Roles of Histone Lysine Methyltransferases in Heart Development and Disease
por: Zhu, Jun-yi, et al.
Publicado: (2023)

Exploration of the Substrate Preference of Lysine Methyltransferase SMYD3 by Molecular Dynamics Simulations
por: Sun, Jixue, et al.
Publicado: (2019)

Cell geometry and the cytoskeleton impact the nucleo-cytoplasmic localisation of the SMYD3 methyltransferase
por: Pereira, David, et al.
Publicado: (2020)

SMYD5 catalyzes histone H3 lysine 36 trimethylation at promoters
por: Zhang, Yanjun, et al.
Publicado: (2022)

Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex
por: Brown, Mark A, et al.
Publicado: (2006)

Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription
por: Yang, Zongcheng, et al.
Publicado: (2023)

The Lysine Methyltransferase SMYD2 Is Required for Definite Hematopoietic Stem Cell Production in the Mouse Embryo
por: Edwards, Melissa A., et al.
Publicado: (2020)

Structural Analysis of SMYD3 Lysine Methyltransferase for the Development of Competitive and Specific Enzyme Inhibitors
por: Jarrell, Dillon K., et al.
Publicado: (2021)

LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2
por: Nguyen, Hannah, et al.
Publicado: (2015)

Molecular Dynamics Simulation Reveals Correlated Inter-Lobe Motion in Protein Lysine Methyltransferase SMYD2
por: Spellmon, Nicholas, et al.
Publicado: (2015)

Symphony of epigenetic and metabolic regulation—interaction between the histone methyltransferase EZH2 and metabolism of tumor
por: Zhang, Tengrui, et al.
Publicado: (2020)

Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers
por: Chen, Rui, et al.
Publicado: (2020)

Mouse myofibers lacking the SMYD1 methyltransferase are susceptible to atrophy, internalization of nuclei and myofibrillar disarray
por: Stewart, M. David, et al.
Publicado: (2016)

Mechanism of the Conformational Change of the Protein Methyltransferase SMYD3: A Molecular Dynamics Simulation Study
por: Sun, Jixue, et al.
Publicado: (2021)

SMYD3: a regulator of epigenetic and signaling pathways in cancer
por: Bernard, Benjamin J., et al.
Publicado: (2021)

Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation
por: Van Aller, Glenn S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_keq99qgqrrjun9jui958r41juc